"Currently, there are many unproven or insufficiently" "proven cell-based treatments commercially available for hopeful individuals seeking cures for a variety of conditions. Typically, these so-called “therapies” are currently being advertised, sold and administered to patients, although they fail to achieve recognized" "biological/medical standards of proof for safety or ef-" "ficacy. In addition, they are often expensive and offered outside the cover of routine clinical care for treat- ments, outside the realm of conventional clinical trials supervised and monitored by regulatory agencies.This paper summarizes a position document to be pub- lished by the International Society for Cellular Therapy (ISCT) as an open manuscript intended for professionals and patient associations. Avoiding a systematic overview of the relevant peer-reviewed literature and investigations, its purpose is to examine multiple aspects of unproven cell therapy interventions including definitions, manufacturing issues, regulations, economic factors and communication.With this document, the ISCT intends to promote a cooperative approach to facilitate the development of safe and effective therapies while minimizing and balancing risks for patients to ultimately establish a coalition of stakeholders that fulfill the vision of a broad, pro-patient cell therapy alliance.

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective / Dominici, Massimo; Nichols, Karen; Srivastava, Alok; Weiss, Daniel J.; Eldridge, Paul; Cuende, Natividad; Deans, Robert J.; Rasko, John E. J.; Levine, Aaron D.; Turner, Leigh; Griffin, Deborah L.; O'Donnell, Lynn; Forte, Miguel; Mason, Chris; Wagena, Edwin; Janssen, William; Nordon, Robert; Wall, Dominic; Ho, Hong Nerng; Ruiz, Milton A.; Wilton, Steve; Horwitz, Edwin M.; Gunter, Kurt C.. - In: CYTOTHERAPY. - ISSN 1465-3249. - 17:12(2015), pp. 1663-1666. [10.1016/j.jcyt.2015.10.007]

Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective

DOMINICI, Massimo;
2015

Abstract

"Currently, there are many unproven or insufficiently" "proven cell-based treatments commercially available for hopeful individuals seeking cures for a variety of conditions. Typically, these so-called “therapies” are currently being advertised, sold and administered to patients, although they fail to achieve recognized" "biological/medical standards of proof for safety or ef-" "ficacy. In addition, they are often expensive and offered outside the cover of routine clinical care for treat- ments, outside the realm of conventional clinical trials supervised and monitored by regulatory agencies.This paper summarizes a position document to be pub- lished by the International Society for Cellular Therapy (ISCT) as an open manuscript intended for professionals and patient associations. Avoiding a systematic overview of the relevant peer-reviewed literature and investigations, its purpose is to examine multiple aspects of unproven cell therapy interventions including definitions, manufacturing issues, regulations, economic factors and communication.With this document, the ISCT intends to promote a cooperative approach to facilitate the development of safe and effective therapies while minimizing and balancing risks for patients to ultimately establish a coalition of stakeholders that fulfill the vision of a broad, pro-patient cell therapy alliance.
2015
17-nov-2015
17
12
1663
1666
Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective / Dominici, Massimo; Nichols, Karen; Srivastava, Alok; Weiss, Daniel J.; Eldridge, Paul; Cuende, Natividad; Deans, Robert J.; Rasko, John E. J.; Levine, Aaron D.; Turner, Leigh; Griffin, Deborah L.; O'Donnell, Lynn; Forte, Miguel; Mason, Chris; Wagena, Edwin; Janssen, William; Nordon, Robert; Wall, Dominic; Ho, Hong Nerng; Ruiz, Milton A.; Wilton, Steve; Horwitz, Edwin M.; Gunter, Kurt C.. - In: CYTOTHERAPY. - ISSN 1465-3249. - 17:12(2015), pp. 1663-1666. [10.1016/j.jcyt.2015.10.007]
Dominici, Massimo; Nichols, Karen; Srivastava, Alok; Weiss, Daniel J.; Eldridge, Paul; Cuende, Natividad; Deans, Robert J.; Rasko, John E. J.; Levine,...espandi
File in questo prodotto:
File Dimensione Formato  
Dominici M et al. PTF Dec_2015 Summary.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 118.33 kB
Formato Adobe PDF
118.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1117734
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 38
social impact